Breaking News Instant updates and real-time market news.

CLDX

Celldex

$11.77 /

+0.23 (+1.99%)

16:18
08/06/20
08/06
16:18
08/06/20
16:18

Celldex reports Q2 EPS (50c), consensus (58c)

Reports Q2 revenue $236K, consensus $800K. "In the second quarter of 2020, we presented data from our KIT inhibitor, CDX-0159, in a late breaking session at the EAACI Annual Congress that suggested significant potential to dramatically impact mast cell driven disorders," said Anthony Marucci, Co-founder, President and Chief Executive Officer of Celldex Therapeutics. "These data provided important proof of concept for the CDX-0159 program and helped support a $150 million public offering driven by high quality health care investors to fully fund the Company's planned operations through 2023. We are on track to initiate two studies in chronic urticaria later this year and are vetting additional mast cell driven indications to support expanded development in 2021." "We continue to focus our resources on the programs we believe hold the most promise for patients and shareholders and have prioritized the development of CDX-0159, CDX-1140, and the first candidate from our bi-specific program, CDX-527. We are discontinuing development of CDX-3379, which is in an exploratory study with cetuximab to assess the utility of biomarkers in head and neck cancer. The side effect profile of the combination remains challenging even with prophylactic treatment and, when considered with the emerging clinical activity, we believe our resources are best utilized to expand the development of CDX-0159 and our other pipeline programs. To this end, we intend to start the two planned studies of CDX-0159 this fall and to initiate a combination cohort of CDX-1140 with chemotherapy in treatment naive metastatic pancreatic cancer and a Phase 1 study of CDX-527 in refractory, advanced cancers later this year. These programs will support data read outs later this year and in 2021," concluded Marucci.

  • 06

    Aug

  • 16

    Jun

CLDX Celldex
$11.77 /

+0.23 (+1.99%)

07/01/20 Cantor Fitzgerald
Celldex price target raised to $18 from $12 at Cantor Fitzgerald
06/12/20 Cantor Fitzgerald
Celldex price target raised to $12 from $8 at Cantor Fitzgerald
02/21/20
Fly Intel: Top five analyst initiations
02/20/20 Cantor Fitzgerald
Celldex initiated with an Overweight at Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Downgrade
Copa Holdings downgraded to Underweight from Overweight at Barclays » 04:58
09/28/20
09/28
04:58
09/28/20
04:58
CPA

Copa Holdings

$55.95 /

+1.44 (+2.64%)

Barclays analyst Pablo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPA Copa Holdings
$55.95 /

+1.44 (+2.64%)

CPA Copa Holdings
$55.95 /

+1.44 (+2.64%)

09/15/20 Seaport Global
Copa Holdings initiated with a Neutral at Seaport Global
08/17/20 Citi
Copa Holdings price target raised to $59 from $51 at Citi
06/22/20 Raymond James
Copa Holdings downgraded to Outperform from Strong Buy at Raymond James
06/22/20 Raymond James
Copa Holdings downgraded to Outperform from Strong Buy at Raymond James
CPA Copa Holdings
$55.95 /

+1.44 (+2.64%)

Upgrade
Huntsman upgraded to Equal Weight from Underweight at Barclays » 04:57
09/28/20
09/28
04:57
09/28/20
04:57
HUN

Huntsman

$21.36 /

+0.095 (+0.45%)

Barclays analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUN Huntsman
$21.36 /

+0.095 (+0.45%)

HUN Huntsman
$21.36 /

+0.095 (+0.45%)

09/16/20 Stifel
Huntsman initiated with a Buy at Stifel
09/09/20 Truist
Huntsman price target raised to $26 from $25 at Truist
09/09/20 KeyBanc
Huntsman price target raised to $29 from $23 at KeyBanc
08/31/20 Goldman Sachs
Huntsman price target raised to $25 from $21 at Goldman Sachs
HUN Huntsman
$21.36 /

+0.095 (+0.45%)

HUN Huntsman
$21.36 /

+0.095 (+0.45%)

HUN Huntsman
$21.36 /

+0.095 (+0.45%)

HUN Huntsman
$21.36 /

+0.095 (+0.45%)

Upgrade
Merit Medical upgraded to Equal Weight from Underweight at Wells Fargo » 04:57
09/28/20
09/28
04:57
09/28/20
04:57
MMSI

Merit Medical

$41.37 /

+0.57 (+1.40%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

07/30/20 Barrington
Merit Medical price target raised to $54 from $49 at Barrington
07/30/20 Piper Sandler
Merit Medical price target raised to $55 from $50 at Piper Sandler
05/27/20 Barrington
Merit Medical price target raised to $49 from $42 at Barrington
05/26/20 Piper Sandler
Piper Sandler positive on Merit Medical's Starboard agreement on board members
MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

MMSI Merit Medical
$41.37 /

+0.57 (+1.40%)

Upgrade
Itron upgraded to Strong Buy from Outperform at Raymond James » 04:56
09/28/20
09/28
04:56
09/28/20
04:56
ITRI

Itron

$56.24 /

+0.79 (+1.42%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITRI Itron
$56.24 /

+0.79 (+1.42%)

ITRI Itron
$56.24 /

+0.79 (+1.42%)

08/25/20 Wolfe Research
Itron initiated with an Underperform at Wolfe Research
08/04/20 Oppenheimer
Itron price target lowered to $75 from $82 at Oppenheimer
06/26/20 Oppenheimer
Itron price target lowered to $82 from $90 at Oppenheimer
05/26/20 Johnson Rice
Itron initiated with a Buy at Johnson Rice
ITRI Itron
$56.24 /

+0.79 (+1.42%)

ITRI Itron
$56.24 /

+0.79 (+1.42%)

Conference/Events
Sarepta to hold a conference call » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
SRPT

Sarepta

$143.72 /

+5.96 (+4.33%)

Management discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRPT Sarepta
$143.72 /

+5.96 (+4.33%)

SRPT Sarepta
$143.72 /

+5.96 (+4.33%)

09/15/20 Citi
Sarepta price target raised to $190 from $177 at Citi
09/10/20 Piper Sandler
Sarepta filing for SRP-9001 could still meet expectations, says Piper Sandler
09/10/20 Mizuho
Sarepta potential study delay 'largely immaterial,' says Mizuho
09/10/20 Goldman Sachs
Sarepta Phase 3 timelines 'could remain intact,' says Goldman Sachs
SRPT Sarepta
$143.72 /

+5.96 (+4.33%)

SRPT Sarepta
$143.72 /

+5.96 (+4.33%)

Conference/Events
Essent Group management to meet virtually with BTIG » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
ESNT

Essent Group

$35.71 /

+0.595 (+1.69%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESNT Essent Group
$35.71 /

+0.595 (+1.69%)

ESNT Essent Group
$35.71 /

+0.595 (+1.69%)

09/21/20
Fly Intel: Top five analyst initiations
09/21/20 Goldman Sachs
Essent Group initiated with a Buy at Goldman Sachs
06/09/20 Keefe Bruyette
Essent Group downgraded to Market Perform from Outperform at Keefe Bruyette
06/03/20 Credit Suisse
Essent Group price target raised to $38 from $32 at Credit Suisse
ESNT Essent Group
$35.71 /

+0.595 (+1.69%)

  • 29
    May
ESNT Essent Group
$35.71 /

+0.595 (+1.69%)

Conference/Events
L.B. Foster to host conference call » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
FSTR

L.B. Foster

$12.16 /

-0.11 (-0.90%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSTR L.B. Foster
$12.16 /

-0.11 (-0.90%)

FSTR L.B. Foster
$12.16 /

-0.11 (-0.90%)

06/09/20 B. Riley FBR
L.B. Foster transferred with Buy, $18 target at B. Riley FBR
05/06/20 B. Riley FBR
L.B. Foster price target lowered to $20 from $30 at B. Riley FBR
General news
Dallas Fed Manufacturing Survey General Activity Index to be reported at 10:30 » 04:55
09/28/20
09/28
04:55
09/28/20
04:55

September Dallas Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
BTIG financials analyst to hold an analyst/industry conference call » 04:55
09/28/20
09/28
04:55
09/28/20
04:55

Financials Analyst Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
TriState Capital management to meet virtually with DA Davidson » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
TSC

TriState Capital

$13.11 /

+0.18 (+1.39%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSC TriState Capital
$13.11 /

+0.18 (+1.39%)

08/05/20 B. Riley FBR
TriState Capital downgraded to Neutral with $15 target at B. Riley FBR
08/05/20 B. Riley FBR
TriState Capital downgraded to Neutral from Buy at B. Riley FBR
06/19/20
Fly Intel: Top five analyst initiations
06/19/20 Wedbush
TriState Capital initiated with an Outperform at Wedbush
TSC TriState Capital
$13.11 /

+0.18 (+1.39%)

  • 06
    Feb
TSC TriState Capital
$13.11 /

+0.18 (+1.39%)

Conference/Events
Bristol-Myers participates in a conference call hosted by Wolfe Research » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
BMY

Bristol-Myers

$59.50 /

+1.26 (+2.16%)

Wolfe Research Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$59.50 /

+1.26 (+2.16%)

BMY Bristol-Myers
$59.50 /

+1.26 (+2.16%)

09/22/20 Oppenheimer
Bluebird Bio review timeline consistent with expectations, says Oppenheimer
08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
BMY Bristol-Myers
$59.50 /

+1.26 (+2.16%)

BMY Bristol-Myers
$59.50 /

+1.26 (+2.16%)

BMY Bristol-Myers
$59.50 /

+1.26 (+2.16%)

BMY Bristol-Myers
$59.50 /

+1.26 (+2.16%)

Conference/Events
DA Davidson technology analysts hold an analyst/industry conference call » 04:55
09/28/20
09/28
04:55
09/28/20
04:55

Technology Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
3-Month Bill Auction to be released at 11:30  04:55
09/28/20
09/28
04:55
09/28/20
04:55
 
Conference/Events
Demant management to meet virtually with JPMorgan » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
WILLF

Demant

$0.00 /

+ (+0.00%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WILLF Demant
$0.00 /

+ (+0.00%)

04/17/20 JPMorgan
Demant price target lowered to DKK 145 from DKK 224 at JPMorgan
04/09/20 Jefferies
Demant price target lowered to DKK 195 from DKK 270 at Jefferies
04/09/20 Jefferies
Sonova downgraded to Hold from Buy at Jefferies
01/16/20 Jefferies
Jefferies European team revamps Franchise Picks list with nine additions
Conference/Events
Daqo New Energy management to meet virtually with Roth Capital » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
DQ

Daqo New Energy

$121.93 /

+1.005 (+0.83%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DQ Daqo New Energy
$121.93 /

+1.005 (+0.83%)

DQ Daqo New Energy
$121.93 /

+1.005 (+0.83%)

08/19/20 Roth Capital
Daqo New Energy price target raised to $150 from $120 at Roth Capital
07/22/20 Roth Capital
Daqo shares should move higher with poly pricing, says Roth Capital
07/20/20 Roth Capital
Roth boosts Daqo target to $120 after polysilicon facility explosion reports
07/08/20 Roth Capital
Daqo New Energy price target raised to $105 from $80 at Roth Capital
DQ Daqo New Energy
$121.93 /

+1.005 (+0.83%)

Conference/Events
TC Energy management to meet virtually with JPMorgan » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
TRP

TC Energy

$44.59 /

+0.645 (+1.47%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRP TC Energy
$44.59 /

+0.645 (+1.47%)

TRP TC Energy
$44.59 /

+0.645 (+1.47%)

08/06/20 BMO Capital
TC Energy price target raised to C$68 from C$65 at BMO Capital
07/15/20 Scotiabank
TC Energy upgraded to Outperform on recent selloff at Scotiabank
07/15/20 Scotiabank
TC Energy upgraded to Outperform from Sector Perform at Scotiabank
07/10/20 US Capital Advisors
TC Energy initiated with a Buy at US Capital Advisors
TRP TC Energy
$44.59 /

+0.645 (+1.47%)

Conference/Events
Aptinyx management to meet virtually with Wedbush » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
APTX

Aptinyx

$3.16 /

+0.02 (+0.64%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTX Aptinyx
$3.16 /

+0.02 (+0.64%)

APTX Aptinyx
$3.16 /

+0.02 (+0.64%)

07/01/20 SunTrust
Aptinyx initiated with a Buy at SunTrust
07/01/20 SunTrust
Aptinyx initiated with a Buy at SunTrust
05/08/20
Fly Intel: Top analyst initiations
05/08/20 William Blair
William Blair starts Aptinyx with Outperform, $10 fair value estimate
APTX Aptinyx
$3.16 /

+0.02 (+0.64%)

  • 10
    Jan
General news
6-Month Bill Auction to be released at 11:30  04:55
09/28/20
09/28
04:55
09/28/20
04:55
 
Conference/Events
Renewable Energy management to meet virtually with Truist » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
REGI

Renewable Energy

$45.13 /

-1.31 (-2.82%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGI Renewable Energy
$45.13 /

-1.31 (-2.82%)

REGI Renewable Energy
$45.13 /

-1.31 (-2.82%)

09/02/20 Roth Capital
Renewable Energy price target raised to $50 from $33 at Roth Capital
09/01/20 Truist
Renewable Energy initiated with a Buy at Truist
09/01/20 Credit Suisse
Renewable Energy initiated with an Outperform at Credit Suisse
09/01/20 Truist
Renewable Energy initiated with a Buy at Truist
REGI Renewable Energy
$45.13 /

-1.31 (-2.82%)

REGI Renewable Energy
$45.13 /

-1.31 (-2.82%)

Conference/Events
X4 Pharmaceuticals management to meet virtually with Roth Capital » 04:55
09/28/20
09/28
04:55
09/28/20
04:55
XFOR

X4 Pharmaceuticals

$6.13 /

-0.16 (-2.54%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
$6.13 /

-0.16 (-2.54%)

XFOR X4 Pharmaceuticals
$6.13 /

-0.16 (-2.54%)

06/12/20 Roth Capital
X4 Pharmaceuticals data boost confidence in Phase 3 study, says Roth Capital
03/26/20 Citi
X4 Pharmaceuticals an attractive buy trading near cash, says Citi
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
02/13/20 Roth Capital
X4 patent strengthens commercial outlook for mavorixafor, says Roth
XFOR X4 Pharmaceuticals
$6.13 /

-0.16 (-2.54%)

  • 26
    Nov
Upgrade
UPS upgraded to Overweight from Sector Weight at KeyBanc » 04:54
09/28/20
09/28
04:54
09/28/20
04:54
UPS

UPS

$166.17 /

+5.755 (+3.59%)

KeyBanc analyst Todd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPS UPS
$166.17 /

+5.755 (+3.59%)

UPS UPS
$166.17 /

+5.755 (+3.59%)

09/24/20 Stifel
Stifel upgrades FedEx to Buy on 'above-average discount' to UPS
09/21/20 Credit Suisse
UPS upgraded to Outperform from Neutral at Credit Suisse
09/17/20 Deutsche Bank
FedEx price target raised to $243 from $150 at Deutsche Bank
09/03/20
Fly Intel: Top five analyst downgrades
UPS UPS
$166.17 /

+5.755 (+3.59%)

UPS UPS
$166.17 /

+5.755 (+3.59%)

UPS UPS
$166.17 /

+5.755 (+3.59%)

UPS UPS
$166.17 /

+5.755 (+3.59%)

Downgrade
Mettler-Toledo downgraded to Neutral from Overweight at JPMorgan » 04:53
09/28/20
09/28
04:53
09/28/20
04:53
MTD

Mettler-Toledo

$974.20 /

+13.66 (+1.42%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTD Mettler-Toledo
$974.20 /

+13.66 (+1.42%)

MTD Mettler-Toledo
$974.20 /

+13.66 (+1.42%)

05/11/20 Wells Fargo
Mettler-Toledo price target raised to $760 from $690 at Wells Fargo
04/09/20 Evercore ISI
Mettler-Toledo downgraded to Underperform from In Line at Evercore ISI
04/09/20 Evercore ISI
Mettler-Toledo downgraded to Underperform from In Line at Evercore ISI
04/02/20 Wolfe Research
Mettler-Toledo downgraded to Underperform from Peer Perform at Wolfe Research
MTD Mettler-Toledo
$974.20 /

+13.66 (+1.42%)

Upgrade
Aviva upgraded to Buy from Hold at Deutsche Bank » 04:53
09/28/20
09/28
04:53
09/28/20
04:53
AVVIY

Aviva

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVVIY Aviva
$0.00 /

+ (+0.00%)

AVVIY Aviva
$0.00 /

+ (+0.00%)

09/25/20 Morgan Stanley
Aviva price target raised to 360 GBp from 349 GBp at Morgan Stanley
09/08/20 Barclays
Aviva price target raised to 367 GBp from 362 GBp at Barclays
08/12/20 Morgan Stanley
Aviva price target lowered to 349 GBp from 366 GBp at Morgan Stanley
07/30/20 RBC Capital
Aviva price target lowered to 370 GBp from 380 GBp at RBC Capital
AVVIY Aviva
$0.00 /

+ (+0.00%)

Upgrade
FedEx upgraded to Buy from Hold at Deutsche Bank » 04:51
09/28/20
09/28
04:51
09/28/20
04:51
FDX

FedEx

$250.26 /

+6.025 (+2.47%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$250.26 /

+6.025 (+2.47%)

FDX FedEx
$250.26 /

+6.025 (+2.47%)

09/24/20
Fly Intel: Top five analyst upgrades
09/24/20 Stifel
Stifel upgrades FedEx to Buy on 'above-average discount' to UPS
09/24/20 Stifel
FedEx upgraded to Buy from Hold at Stifel
09/17/20 Deutsche Bank
FedEx price target raised to $243 from $150 at Deutsche Bank
FDX FedEx
$250.26 /

+6.025 (+2.47%)

FDX FedEx
$250.26 /

+6.025 (+2.47%)

FDX FedEx
$250.26 /

+6.025 (+2.47%)

FDX FedEx
$250.26 /

+6.025 (+2.47%)

Upgrade
GP Strategies upgraded to Buy from Neutral at B. Riley FBR » 04:50
09/28/20
09/28
04:50
09/28/20
04:50
GPX

GP Strategies

$9.12 /

+0.06 (+0.66%)

B. Riley FBR analyst Zach…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPX GP Strategies
$9.12 /

+0.06 (+0.66%)

GPX GP Strategies
$9.12 /

+0.06 (+0.66%)

05/13/20 Roth Capital
GP Strategies price target lowered to $8 from $18 at Roth Capital
05/08/20 B. Riley FBR
GP Strategies downgraded to Neutral from Buy at B. Riley FBR
03/10/20 Barrington
GP Strategies price target lowered to $15 from $20 at Barrington
01/06/20 B. Riley FBR
GP Strategies named top Software & Business Services pick at B. Riley FBR
GPX GP Strategies
$9.12 /

+0.06 (+0.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.